Skip to main content

Table 2 Cross-reactivity of probes used for in situ hybridization

From: MARK4 and MARK3 associate with early tau phosphorylation in Alzheimer’s disease granulovacuolar degeneration bodies

  MARK1 MARK2 MARK3 MARK4
Length 580 bp 600 bp 590 bp 601 bp
MARK1 100% 38.7% 55.6% 50.4%
MARK2 51.9% 100% 36.1% 52.6%
MARK3 55.9% 39.3% 100% 52.2%
MARK4 48.1% 42.3% 46.6% 100%
  1. Percentages are overall sequence identity of probes toward each MARK family isoform.